Identification of Epigenetic Regulatory Networks of Gene Methylation–miRNA–Transcription Factor Feed-Forward Loops in Basal-like Breast Cancer
Cells · 2025
DOI: 10.3390/cells14161235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Larissa M Okano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, DNA Methylation, Gene Regulatory Networks. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Basal-like breast cancer (BLBC) is associated with poor prognosis, high recurrence rates, and limited therapeutic options, largely due to its molecular heterogeneity and complexity, which include epigenetic alterations. This study investigated epigenetic regulatory networks in BLBC by analyzing DNA methylation in distal cis-regulatory regions and its impact on genes, transcription factors (TFs), and microRNAs (miRNAs) expression. Data from TCGA were processed using the ELMER and DESeq2 tools to identify differentially methylated regions and differentially expressed genes, TFs, and miRNAs. The FANMOD algorithm was used to identify the regulatory interactions uncovering the feed-forward loops (FFLs). The analysis identified 110 TF-mediated FFLs, 43 miRNA-mediated FFLs, and five composite FFLs, involving 18 hypermethylated and 32 hypomethylated genes, eight upregulated and nine downregulated TFs, and 21 upregulated and seven downregulated miRNAs. The TF-mediated FFLs major regulators involved the AR, EBF1, FOS, FOXM1, and TEAD4 TFs, while key miRNAs were miR-3662, miR-429, and miR-4434. Enriched pathways involved cAMP, ErbB, FoxO, p53, TGF-beta, Rap1, and Ras signaling. Differences in hallmark gene set categories reflected distinct methylation and miRNA expression profiles. Overall, this integrative analysis mapped the intricate epigenetic landscape of BLBC, emphasizing the role of FFLs as regulatory motifs that integrate DNA methylation, TFs, and miRNAs in orchestrating disease’s development and progression and offering potential targets for future diagnostic and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.
- Genetics Department, Federal University of Paraná, Curitiba 80060-000, PR, Brazil.
- School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto 14040-903, SP, Brazil.
- Bioinformatics and Systems Biology Laboratory, Federal University of Paraná, Curitiba 81520-260, PR, Brazil.
- Oncology Department, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
ORCID-Profile: Larissa M Okano, Jessica M Magno, Bonald C Figueiredo, Mauro A A Castro
Zitieren
APA
Okano, L. M., de Azevedo, A. L. K., Carvalho, T. M., Resende, J., Magno, J. M., Figueiredo, B. C., Malta, T. M., Castro, M. A. A., & Cavalli, L. R. (2025). Identification of Epigenetic Regulatory Networks of Gene Methylation–miRNA–Transcription Factor Feed-Forward Loops in Basal-like Breast Cancer. Cells. https://doi.org/10.3390/cells14161235
Vancouver
Okano LM, de Azevedo ALK, Carvalho TM, Resende J, Magno JM, Figueiredo BC, et al. Identification of Epigenetic Regulatory Networks of Gene Methylation–miRNA–Transcription Factor Feed-Forward Loops in Basal-like Breast Cancer. Cells. 2025. doi:10.3390/cells14161235
BibTeX
@article{Okano2025,
author = {Okano, Larissa M and de Azevedo, Alexandre L K and Carvalho, Tamyres M and Resende, Jean and Magno, Jessica M and Figueiredo, Bonald C and Malta, Tathiane M and Castro, Mauro A A and Cavalli, Luciane R},
title = {Identification of Epigenetic Regulatory Networks of Gene Methylation–miRNA–Transcription Factor Feed-Forward Loops in Basal-like Breast Cancer},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14161235}
}
EUVIMED